Modern Postoperative Pain to the Treatment Approaches in Oncogynecology

I.I. Khusainova1, A.Zh. Bayalieva1,2, M.К. Browne1

1 Kazan State Medical University (KSMU), Kazan

2 Department of Anesthesiology and Reanimatology, disaster medicine KSMU of the Ministry of Health of the Russian Federation

For correspondence: Aynagul Zholdoshevna Bayalieva — Doct. of Med. Sci., Docent, Head of the Department of Anesthesiology and Reanimatology, disaster medicine of KSMU; e-mail: bayalieva1@yandex.ru

For citation: Khusainova II, Bayalieva AZh, Browne MК. Modern Postoperative Pain to the Treatment Approaches in Oncogynecology. Intensive Care Herald. 2017;4:13–18.


Effective postoperative analgesia is one of the successful rehabilitation conditions. Mechanisms of postoperative pain have been being studied by now, and more new analgesics and anesthesia techniques are introduced. The range of surgical interventions in oncogynecology is wide: from minimally invasive laparoscopic operations to radical hysterectomies involving healthy tissues and removal of regional lymph nodes. Postoperative pain following radical hysterectomy with an intensity of more than 6 on visual analogue scale (VAS) requires multimodal pain therapy. Inadequate pain management leads to its transformation to a chronic condition, a neuropathic pain, associated with not fully reversible changes in patient’s brain. This article is based on the results of a systematic literature review developed by PROSPECT (cooperation of surgeons and anaesthesiologists in developing guidelines for specific procedures and manipulations). It deals with optimization of pain management highlighting new post-operative care principles.

Keywords: postoperative pain, balanced multimodal analgesia

Received: 09.06.2017


References

  1. Hahnenkamp K., Herroeder S., Hollmann M.W. Regional an- aesthesia, local anaesthetics and the surgical stress response. Best Pract. Res. Clin. Anaesthesiol. 2004;18(3): 509–527.
  2. Kehlet H. The stress response to surgery: release mechanisms and the modifying effect of pain relief. Acta Scand. Suppl. 1989; 550: 22–28.
  3. Tetzlaff J.E. Cousins and Bridenbaugh’s Neural Blockade in Clinical Anesthesia and Pain Medicine. Mayo Clin. Proc. 2010; 85(7): e51. doi: 4065/mcp.2010.0230.
  4. Wall & Melzack’s Textbook of Pain. 6th URL: https://www.elsevier.com/books/wall-and-melzacks-textbook-of-pain/mcmahon/978-0-7020-4059-7. Accessed September 23, 2017.
  5. Misiołek H., Cettler M., Woroń J., Wordliczek J., Dobrogows- ki J., Mayzner-Zawadzka E. The 2014 guidelines for post-operative pain management. Anaesthesiol. Intensive Ther. 2014; 46(4): 221–244. doi: 5603/AIT.2014.0041.
  6. Griensven H., Strong J., Unruh A. Pain. A Textbook for Health Professionals. 2nd Elsevier. Churchil Livingstone, 2014: 430– 431.
  7. Овечкин А.М., Политов М.Е. Послеоперационное обезболивание с точки зрения доказательной медицины. Вестник интенсивной терапии. 2016; 2: 51–60. [Ovechkin A.M. Politov M.E. Postoperative analgesia from evidence based medi- cine. Vestnik Intensivnoi 2016; 2: 51–60. (In Russ)]
  8. Овечкин А.М. Послеоперационная боль и обезболивание: современное состояние проблемы. Медицина неотложных состояний. 2011; 6: 37. [Ovechkin A.M. Postoperative pain and anesthesia: the current state of the problem. Emergency medicine. 2011; 6: 37. (In Russ)]
  9. Осипова Н.А., Петрова В.В., Береснев В.А., Митрофанов С.В. Современные средства и методы анестезии и анальгезии в большой хирургии. Регионарная анестезия и лечение боли: тематический сборник. Москва-Тверь, 2004; 7–16. [Osipova N.A, Petrova V.V., Beresnev V.A., Mitrofanov S.V. Modern Means and Methods of Anesthesia and Analgesia in the General Surgery. Regional Anesthesia and Pain Management. Thematic Collection. Moscow-Tver, 2004; 7–16. (In Russ)]
  10. Rawal N., Andres J., Fischer B.J. et al. Postoperative pain management — good clinical practice. General recommendations and principles for successful pain management. General recommendations and principles for successful pain management. Produced with the consultation with the Europeans Society of Regional Anaesthesia and Pain Therapy. 2005. URL: http:// polanest.webd.pl/pliki/varia/books/PostoperativePainManagement.pdf.
  11. Осипова Н.А., Абузарова Г.Р., Петрова В.В. Принципы применения анальгетических средств при острой и хронической боли. М.: ФГБУ «МНИОИ им. П.А. Герцена Минздравсоцразвития России», 2010. [Osipova N.A., Abuzarova G.R., Petro- va V.V. Principles of using analgesics for acute and chronic pain. Moscow: A. Herzen Moscow Oncology Research Institute (MNIOI P.A. Gertsena), Ministry of Health and Social Development of Russia, 2010. (In Russ)]
  12. Dolin S.J., Cashman J.N., Bland J.M. Effectiveness of acute postoperative pain management: I. Evidence from published data. J. Anaesth. 2002; 89(3): 409–423.
  13. Кукушкин М.Л. Общая патология боли: руководство для врачей. Медицина, 2004. [Kukushkin M.L. General pathology of pain. A guide for doctors. Medicine, 2004. (In Russ)]
  14. Wei H., Karimaa M., Korjamo T., Koivisto A., Pertovaara A. Transient receptor potential ankyrin 1 ion channel contributes to guarding pain and mechanical hypersensitivity in a rat model of postoperative pain. 2012; 117(1): 137–148. doi: 10.1097/ALN.0b013e31825adb0e.
  15. Спасова А.П., Барышева О.Ю. Методы объективизации боли и связанных с нею расстройств. Министерство образования и науки РФ, ФГБОУ ВПО «Петрозаводский гос. ун-т». Петрозаводск: Издательство ПетрГУ, [Spasova A.P., Barysheva O.Yu. Methods of Objectivization of Pain and Related Disorders. Ministry of Education and Science Russian Federation, Federal State Budget Educated Institution of higher continuous education Petrozavodsk State University. Petrozavodsk: Publishing house PetrSU, 2015. (In Russ)]
  16. Голуб И.Е., Сорокина Л.В. Хирургический стресс и обезбо- ливание. Иркутск: ИГМУ, [Golub I.E., Sorokina L.V. Sur- gical stress and anesthesia. Irkutsk State Medical University (ISMU), 2005. (In Russ)]
  17. Овечкин А.М. Влияние регионарной анестезии и анальгезии на результаты хирургического лечения. Регионарная анестезия и лечение острой боли. 2015; 1: 45–54. [Ovechkin A.M. The effect of regional anesthesia and analgesia on the results of surgical treatment. Regional anesthesia and treatment of acute pain. 2015; 1: 45–54. (In Russ)]
  18. Harsoor S. Emerging concepts in post-operative pain management. Indian J. Anaesth. 2011; 55(2): 101–103. doi: 4103/0019-5049.79872.
  19. Mamittz S., Kohler C. Current therapy of patients with endo- metrial carcinoma. A critical review. Strahlenther. Onkol. 2012; 188(1): 12–20. doi: 1007/s00066-011-0004-0.
  20. Lim P.C., Crane J.T., English E.J. et al. Multicenter analysis comparing robotic, open, laparoscopic, and vaginal hysterectomies performed by high-volume surgeons for benign Int. J. Gynaecol. Obstet. Off Organ. Int. Fed. Gynaecol. Obstet. 2016; 133(3): 359–364. doi: 10.1016/j.ijgo.2015.11.010.
  21. Бохман Я.В. Руководство по онкогинекологии. М.: Книга по требованию, 2012. [Bohman Ya.V. Manual on oncogy Moscow: The book on Demand, 2012. (In Russ)]. URL: http://static.my-shop.ru/product/pdf/155/1544646.pdf.
  22. Coughlin S.M., Karanicolas P.J., Emmerton-Coughlin H.M., Kanbur B., Kanbur S., Colquhoun P.H. Better late than never? Impact of local analgesia timing on postoperative pain in laparoscopic surgery: a systematic review and metaanalysis. Endosc. 2010; 24(12): 3167–3176. doi: 10.1007/s00464-010-1111-1.
  23. Hong J.Y., Lim K.T. Effect of preemptive epidural analgesia on cytokine response and postoperative pain in laparoscopic radical hysterectomy for cervical Reg. Anesth. Pain Med. 2008; 33(1): 44–51.
  24. Azari L., Santoso J.T., Osborne S.E. Optimal pain management in total abdominal hysterectomy. Gynecol. Surv. 2013; 68(3): 215–227. doi: 10.1097/OGX.0b013e31827f5119.
  25. Горобец Е.С., Груздев Е.В., Зотов А.В., Типисев Д.А., Шин А.Р. Концепция мультимодальной комбинированной анестезии и безопасность травматичных операций. Регионарная анестезия и лечение острой боли. 2009; 1: 39– [Gorobets E.S., Gruzdev E.V., Zotov A.V., Tipisev D.A., Shin A.R. The concept of multimodal combined anesthesia and the safety of traumatic surgeries. Regional. anesthesia and treatment of acute pain. 2009; 1: 39–45. (In Russ)]
  26. Наумов А.В., Семенов П.А., Мендель О.И. Стратегия ведения послеоперационного болевого синдрома: фокус на мультимодальную анальгезию. Consilium 2010; 12(8): 104–107. [Naumov A.V., Semenov P.A., Mendel O.I. The strategy of conducting postoperative pain syndrome: fo- cus on multimodal analgesia. Consilium Medicum. 2010; 12(8): 104–107. (In Russ)]
  27. Страчунский Л.С. Нестероидные противовоспалительные средства: методическое пособие. Смоленск: СГМА, 2008. [Strachunsky L.S. Non-steroidal anti-inflammatory drugs, methodical manual. Smolensk State Medical Academy (SGMA), 2008. (In Russ)]
  28. Bekawi M.S., El Wakeel L.M., Al Taher W.M., Mageed W.M. Clinical study evaluating pregabalin efficacy and tolerability for pain management in patients undergoing laparoscopic Clin. J. Pain. 2014; 30(11): 944–952. doi: 10.1097/ AJP.0000000000000060.
  29. Buck M., Blumer J. Opioids and other analgesics: Adverse effects in the intensive care Crit. Care Clin. 1991; 7: 615–637.
  30. Buvanendran A., Kroin J.S. Multimodal analgesia for controlling acute postoperative pain.Curr. Opin. Anaesthesiol. 2009; 22(5): 588–593. doi: 1097/ACO.0b013e328330373a.
  31. Horlocker T.T., Kopp S.L., Pagnano M.W., Hebl J.R. Analgesia for total hip and knee arthroplasty: a multimodal pathway featuring peripheral nerve block. J. Am. Acad. Orthop. Surg. 2006; 14(3): 126–135.
  32. Goucke C.R., Jackson T., Morriss W., Royle J. Essential pain management: an educational program for health care workers. World Surg. 2015; 39(4): 865–870. doi: 10.1007/s00268-014- 2635-7.
  33. Jain A.K., Kumar S., Tyagi A. Practice trends in use of morphine for control of intraoperative pain: An audit. J. Anaesthe- siol. Clin. Pharmacol. 2012; 28(1): 62–65. doi: 10.4103/0970- 9185.92440.
  34. Jørgensen H., Wetterslev J., Møiniche S., Dahl J.B. Epidural local anaesthetics versus opioid-based analgesic regimens on postoperative gastrointestinal paralysis, PONV and pain after abdominal surgery. Cochrane Database Syst. 2000; 4: CD001893. doi: 10.1002/14651858.CD001893.
  35. Correll D.J., Vlassakov K.V., Kissin I. No evidence of real prog- ress in treatment of acute pain. Journal of pain research. 2014; 7: 199–210. doi: 2147/JPR.S60842.
  36. Alimian M., Pournajafian A., Kholdebarin A., Ghodraty M., Rokhtabnak F., Yazdkhasti P. Analgesic effects of paracetamol and morphine after elective laparotomy surgeries. Pain Med. 2014; 4(2): e12912. doi: 10.5812/aapm.12912.
  37. Gerbershaden M.U. Procedure-specific postoperative pain treatment. 2015. URL: https://dspace.library.uu.nl/bit- stream/1874/311168/1/Gerbershagen.pdf.
  38. Kehlet H. Labat lecture 2005: surgical stress and postoperative outcome-from here to where? Anesth. Pain Med. 2006; 31(1): 47–52. doi: 10.1016/j.rapm.2005.10.005.
  39. Kehlet H., Werner M., Perkins F. Balanced analgesia: what is it and what are its advantages in postoperative pain? Drugs. 1999; 58(5): 793–797.

The Influence of Polymorphism of the Μ-opioid Receptor OPRM1 A118G on the Doses of Narcotic Analgesics in the Early Postoperative Period (Meta-Analysis)

O.A. Makharin, V.M. Genilo

Rostov state medical University, Department of anesthesiology and reanimatology, Rostov-on-don

For correspondence: Oleg A. Makharin — MD, assistant of Department of anesthesiology and reanimatology of Rostov state medical university, Rostov-on-don; e-mail: olegmaharin@yandex.ru

For citation: Makharin OA, Genilo VM. The Influence of Polymorphism of the μ-Opioid Receptor OPRM1 A118G on the Doses of Narcotic Analgesics in the Early Postoperative Period (Meta-Analysis). Intensive Care Herald. 2017;3:48–52. 


The aim of the study was the compilation and analysis of available data on the influence of polymorphism of the μ-opioid receptor OPRM1 A118G on the doses of narcotic analgesics in the early postoperative period. Materials and methods. The information was taken from SCO- PUS, MedLine, EMBASE. We analyzed 34 studies. The inclusion criteria in meta-analysis: the original study on this issue. Exclusion criteria: reviews, articles concerning the influence of polymorphism on pain not related to surgical treatment (childbirth, cancer pain, chronic pain), as well as papers in which the authors studied the influence of polymorphism of the μ-opioid receptor OPRM1 A118G on the doses of narcotic analgesics infused in the epidural or intrathecal space. 6 works (1691 patients) were included in the meta-analysis. We analyzed the difference in the need for narcotic analgesics in the first 24 hour. Results. We found that homozygous carriers of A-allele of the μ-opioid receptor OPRM1 needed lower doses of narcotic analgesics compared with heterozygous (fixed effects model; Z = −10,172; p = 0.0001; I2 = 54.1 per cent), and homozygous carriers of G-allele(fixed effects model; Z = −6,543; p = 0.0001; I2= 81,7 %). Conclusion. Polymorphism of the μ-opioid receptor OPRM1 A118G affects the individual need for narcotic analgesics in the early postoperative period.

Keywords: μ-opioid receptor , рolymorphism, postoperative pain, analgesia

Received: 04.03.2017


References

  1. Овечкин А.М., Шадрин Р.В., Шифман Е.М., Заболотских И.Б. Возможности и перспективы внедрения рекомендаций Американского общества боли по лечению послеоперационной боли (2016) в российскую клиническую практику, с учетом законодательных норм РФ, финансовой политики в области здравоохранения и традиционных подходов к лечению боли.
  2. Регионарная анестезия и лечение острой боли. 2017; прил. 1: S4–S42. doi: 10.18821/1993-6508-2017-11-Supplement01-S4-S42. [Ovechkin A.M., Shadrin R.V., Shifman E.M., Zabolotskikh I.B. Vozmozhnosti i perspektivy vnedreniya rekomendatsiy amerikanskogo obshchestva boli po lecheniyu posleoperatsionnoy boli (2016) v rossiyskuyu klinicheskuyu praktiku, s uchetom zakonodatel’nykh norm RF, finansovoy politiki v oblasti zdravookhraneniya i traditsionnykh podkhodov k lecheniyu boli. Regionarnaya anesteziya i lechenie ostroy boli. 2017; prilozhenie 1: S4–S42. (In Russ)]
  3. Осипова Н.А. Послеоперационное обезболивание в России: клинические и организационные аспекты. Общая реаниматология. 2013; 9(4): 5–10. [Osipova N.A. Posleoperatsionnoe obezbolivanie v Rossii: klinicheskie i organizatsionnye Obshchaya reanimatologiya. 2013; 9(4): 5–10. (In Russ)]
  4. Дугиева М.З., Свиридов С.В., Слепцова Н.И., Морозова К.В. Факторы риска развития длительного болевого синдрома после гинекологических операций. Общая реаниматология. 2012; 8(5): 56–60. [Dugieva M.Z., Sviridov V., Sleptsova N.I., Morozova K.V. Faktory riska razvitiya dlitel’nogo bolevogo sindroma posle ginekologicheskikh operatsiy. Obshchaya reanimatologiya. 2012; 8(5): 56–60. (In Russ)]
  5. Huang P., Chen C., Mague S.D. et al. A common single nucleotide polymorphism A118G of the μ-opioid receptor alters its N-glycosylation and protein stability. Biochem. J. 2012; 441(1): 379–386. doi: 1042/BJ20111050.
  6. Bond C., LaForge K.S., Tian M. et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate ad- diction. Natl. Acad. Sci. USA. 1998; 95(16): 9608–9613.
  7. Chou W.Y., Wang C.H., Liu H. et al. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology 2006; 105: 334–337.
  8. Zhang W., Yuan J., Kan Q.C. Association of human micro-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients. Anaesthesia. 2010; 65(2): 130–135.
  9. Chou W.Y., Yang C., Lu H.F. et al.. Association of mu-opioid receptor gene polymorphism (A118G) with variations in mor- phine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol. Scand. 2006; 50: 787–792.
  10. Zhang W., Yuan J.J., Kan Q.C. et al. Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous Minerva Anestesiol. 2011; 77: 33–39.
  11. Boswell M.V., Stauble M.E., Loyd G.E. et al. The role of hydromorphone and OPRM1 in postoperative pain relief with Pain Physician. 2013; 16: E227–E235.
  12. Tan C., Lim E.C., Teo Y.Y. et al. Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol. Pain. 2009; 5: 32.
  13. Дембицкий C.С. Метаанализ: ключевые понятия и основы вычислений (на примере данных кросс-национальных исследований). Социология: теория, методы, маркетинг. 2012; 3: 160–174. [Dembitskiy S. Metaanaliz: klyuchevye ponyatiya i osnovy vychisleniy (na primere dannykh kross-natsional’nykh issledovaniy). Sotsiologiya: teoriya, metody, marketing. 2012; 3: 160–174. (In Russ)]
  14. Ren Y., Xu X.Q., Bao Y.P. et al. The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. Pain Physician. 2015; 18(2): 131–152.
  15. Bond C., LaForge K.S., Tian M. et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate ad- diction. Natl. Acad. Sci. USA. 1998; 95(16): 9608–9613.
  16. Oertel B.G., Kettner M., Scholich K. et al. A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of J. Biol. Chem. 2009; 284(10): 6530–6535.
  17. Crist R.C., Berrettini W.H. Pharmacogenetics of OPRM1. Biochem. Behav. 2014; 123: 25–33.
  18. Nestler E.J. Common molecular and cellular substrates of addiction and memory. Neurobiol. Learn. Mem. 2002; 78(3): 637–647.

Experience of Multimodal Non Opioid Analgesia after Highly Traumatic after Cancer Surgery in the Head and Neck

V.V. Balandin, E.S. Gorobets

FGBU «Russian Cancer Research Center. n.a. N.N. Blokhin», Moscow

For citation: Balandin VV, Gorobets ES. Experience of Multimodal Non Opioid Analgesia after Highly Traumatic Cancer Surgery in the Head and Neck. Intensive Care Herald. 2016;2:70–73.


Introduction. 80 clinical observations of the adult patients who underwent high-traumatic operations for tumors of the head and neck. Materials and methods. Anesthesia: an admixture of a Nefopam of 1 % 12 ml (120 mg), Lidocainum of 1 % 284 ml (2840 mg) and a Tenoksikam of 1 % 4 ml (40 mg) intravenously with the help of disposable elastomeric infusional pump (volume 300 ml) within 2 days after operation with rate of 6–8 ml/h are presented. Efficiency of anesthesia was estimated by 10-point visual- analog score system (VAS). Intensity of pain didn’t exceed 2.8 ± 0.84 points on the first, and 2.3 ± 0.68 on the second postoperative day. Additional anesthesia was required to 21 % of patients during the first 24 hours and for 12.5 % of patients at the second postoperative day. It was necessary to add narcotic analgetics only at 8.5 % of patients on the first and 3.5 % on the second day after operation. Results. Side effects were revealed in 8 % of patients and include: tachycardia, nausea and a sweating. Conclusions. The presented results demonstrate strong analgetic effect of the developed scheme of anesthesia and its safety. The technique provided early activization of patients, excluding or minimizing use of narcotic analgetics during the postoperative period.

Keywords: postoperative pain, multimodal analgesia, head and neck tumors, nefopam, lidocaine, NSAIDS

Received: 26.04.2016


References

  1. Bilotta F., Pietropaoli P., Sanita R. Nefopam and tramadol for the prevention of shivering during neuroaxial anesthesia. Reg. Anesth. Pain. Med. 2002; 27: 380–384.
  2. Delage N., Maaliki H., Beloeil H. Median effective dose (ED50) of nefopam and ketoprofen in postoperative patients. Anesthesiol 2005; 102: 1211–1216.
  3. Fernandez-Sanchez М., Diaz-Trelles R., Groppetti A. Nefopam, an analogue of or-phenadrine, protects against both NMDA receptor-dependent and independent vera-tridine-induced neurotoxicity. Amino Acids. 2002; 23: 31–36.
  4. Girard P., Verniers D., Coppe M.-C. Nefopam and ketoprofen synergy in rodent models of antinociception. Eur. J. Pharm. 2008; 584: 263–271.
  5. Herminghaus A., Wachowiak M., Wilhelm W. Intravenous administration of lidocaine for perioperative analgesia. Rewiew and recommendations for practical usage. Anesthesist. 2011; 60(2): 152–
  6. Herroeder S., Pecher S., Schonherr M.E. et al. Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology. 2007; 106: 11–86.
  7. Kehlet H., Dahl J.B. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth. Analg. 1993; 77: 1048–1056.
  8. Kehlet H. Labat Lecture 2005. Surgical stress and postoperative outcome — from here to where? Anesth. Pain Med. 2006; 31: 47–52.
  9. Marret E., Rolin M., Beaussier M., Bonnet F. Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br. J. Surg. 2008; 95(11): 1331–1338.
  10. Piper S., Rohm K., Suttner S. A comparison of nefopam and clonidine for the prevention of postanaesthetic shivering: a comparative, double-blind and placebo-controlled dose-ranging study. 2004; 59: 559–564.
  11. Verleye M., Andre N., Heulard I., Gillardin J. Nefopam blocks voltagesensitive sodium channels and modulates glutamatergic transmission in rodents. Brain Res. 2004; 1013: 249–2
  12. Баландин В.В., Горобец Е.С. Послеоперационное обезболивания нефопамом и НПВП у больных, оперированных по поводу опухолей области головы и шеи. Анестезиология и реаниматология. 2014; 1: 40–43.
  13. Баландин В.В., Горобец Е.С. Безопиоидная анестезия, анальгезии и седация в хирургии опухолей головы и шеи. Анестезиология и реаниматология. 2015; 60(6): 39–42.
  14. Овечкин А.М., Свиридов С.В. Послеоперационная боль и обезболивание: современное состояние проблемы. Медицина критических состояний. 2011; 6(37): 20–31.

Evidence-based Medicine’s Point of View on Postoperative Analgesia

A.M. Ovechkin, M.E. Politov

First Moscow Medical State University of I.M. Sechenov, Moscow

For citation: Ovechkin AM, Politov ME. Evidence-based Medicine Point of View on Postoperative Analgesia. Intensive Care Herald. 2016;2:51–60.


The review considers modern approaches to postoperative pain management from the standpoint of evidence-based medicine. Adequate postoperative analgesia, according to foreign literature, does not exceed 50 %. Today the basis for postoperative analgesia is the concept of multimodal analgesia. Data EBM substantiated the combined use of schemes of multimodal analgesia: opioids, non-opioid analgesics (NSAIDs, paracetamol), adjuvant drugs (ketamine, gabapentinoids) and different variants of regional analgesia. From all drug combinations best evidence base has a combination of NSAIDs and paracetamol. In the presence of contraindications to NSAIDs, they may be replaced by a centrally acting analgesic drug — nefopam. The schemes of multimodal analgesia should be built individually for each type of surgical intervention, having regard to the features of post-operative pain syndrome after these interventions, as well as to the individual features of patient.

Keywords: postoperative pain, multimodal analgesia, non-opioid analgesics, regional analgesia

Received: 14.06.2016


References

  1. Benhamou D., Berti M., Brodner G. Postoperative analgesic therapy observational survey (PATHOS): a practice pattern study in 7 central/southern European countries. Pain. 2008; 136: 134–141.
  2. Dolin S., Cashman J., Bland J. Effectiveness of acute postoperative pain management: I. Evidence from published data. Br. J. Anae 2002; 89: 409–423.
  3. Institute of Medicine. Relieving pain in America. USA: National Academies Press, 2011; ISBN-13.9780-0-309-21484-1.
  4. Gan T., Habib A., Miller T. et al. Incidence, patient satisfaction, perception of postsurgical pain: results from a US national survey. Curr. Med. Res. Opin. 2014; 30: 149–160.
  5. Management of Postoperative Pain: A Clinical Practice Guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. The Journal of Pain. 2016; 17(2): 131–157.
  6. Acute Pain Management: Scientific Evidence. Australian and New Zeland College of Anaesthetists, 3rd Eds.: P. Macintyre, D. Scott, S. Schug. 2010.
  7. Oderda G., Gan T. Effect of opioid-related adverse events on outcomes in selected surgical patients. J. Pain Palliat. Care Pharmacother. 2013; 27: 62–70.
  8. Nasir D., Howard J., Joshi G., Hill G. A survey of acute pain service structure and function in United States hospitals. Pain Res. Treat. 2011; 2011: 934932.
  9. Laulin J.-P., Maurette P., Rivat C. The role of ketamine in preven ting fentanyl­unduced hyperalgesia and subsequent acute morphine tolerance. Analg. 2002; 94: 1263–1269.
  10. Gottschalk A., Sharma S., Ford J. The role of the perioperative period in recurrence after cancer surgery. Analg. 2010; 110: 1636–1643.
  11. Stubhaug A., Romundstad L., Kaasa T., Breivik H. Methylprednisolone and ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds. Acta Anaesth. Scand. 2007; 51: 1138–1146.
  12. Forrest J., Kamu F., Greer I. Ketorolack, diclofenac and ketoprofen are equally safe for pain relief after major surgery. Brit. Anaesth. 2002; 88: 227–233.
  13. Schjerning Olsen A-M., Fosbol E., Lindhardsen J. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. Circulation. 2011; 123: 2226–2235.
  14. S. Food and Drug Administration: Information for Healthcare Professionals: Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Accessed October 30, 2014.
  15. Li Q., Zhang Z., Cai Z. High-dose ketorolac affects adult spinal fusion: A meta-analysis of the effect of periperative nonsteroidal anti-inflammatory drugs on spinal fusion. Spine. 2011; 36: E461–E468.
  16. Dodwell E., Latorre J., Parisini E. et al. NSAID exposure and risk of nonunion: A metaanalysis of case-control and cohort studies. Calcif. Tissue Int. 2010; 87: 193–202.
  17. Mimoz O., Chauvet S., Gregoire N. Nefopam pharmacokinetics in patients with end-stage renal disease. Anesth. Analg. 2010; 111: 1146–1153.
  18. Delage N., Maaliki H., Beloeil H. Median effective dose (ED50) of nefopam and ketoprofen in postoperative patients. Anesthesiol 2005; 102: 1211–1216.
  19. Durrieu G., Oliver P., Bagheri H. Overview of adverse reactions to nefopam: an analysis of French pharmacovigilance database. Clin. Pharmacol. 2007; 21: 555–558.
  20. McCartney C., Sinha A., Katz J. A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia. Analg. 2004; 98: 1385–1400.
  21. De Kock M. Expanding our horisons: transition of acute postoperative pain to persistent pain and establishment of chronic postsurgical pain service. Anesthesiology. 2009; 111: 461–463.
  22. Lauretti G. Mechanisms of analgesia of Intravenous lidocaine. Rev. Bras. Anestesiol. 2008; 58(3): 280–286.
  23. Cohen S., Mao J. Is the analgesic effect of systemic lidocaine mediated through opioid receptors? Acta Anaesthesiol. Scand. 2003; 47: 910–911.
  24. Nagy I., Woolf C. Lignocaine selectivity reduces C fibreevoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated postsynaptic depolarizations; implications for the development of novel centrally acting analgesics. Pain. 1996; 64: 59–70.

Postoperative analgesia in the surgical treatment of non-traumatic subarachnoid hemorrhage

A.Zh. Bayalieva1,2, R.Ja. Shpaner1,2, I.R. Ganeeva1,2

1 Kazan State Medical University, Kazan, Russian Federation

2 Interregional Clinical Diagnostic Center, Kazan, Russian Federation

For correspondence: Bayalieva Aynagul Zholdoshevna, Head of the Department of Anesthesiology and Reanimatology, disaster medicine of KSMU; e-mail: bayalieva1@yandex.ru

For citation: Bayalieva AZh, Shpaner RJa, Ganeeva IR. Postoperative Analgesia in the Surgical Treatment of Non-Traumatic Subarachnoid Hemorrhage. Alexander Saltanov Intensive Care Herald. 2018;1:37–42.

DOI: 10.21320/1818-474X-2018-1-37-42


The aim of the study was evaluation of headache treatment effectiveness in patients with non-traumatic subarachnoid hemorrhage, after surgical clipping of the aneurysm. The study included 105 patients, depending on the multimodal pain control method used, the following groups were formed: I — dexketoprofen or paracetamol; II — gabapentin plus dexketoprofen or paracetamol; III — Transdermal therapeutic system, the active element of which is fentanyl plus dexketoprofen or paracetamol. The drug of the reserve in all three groups was tramadol. The adequacy of the methods was judged by analgesic ability, using the Visual-Analog scale, and by the degree of influence on the level of consciousness, using of the Richmond Agitation-Sedation Scale. When evaluating the effectiveness of the methods, it was found that the combination of gabapentin and dexketoprofen/paracetamol is the most acceptable for this category of patients.

Keywords: postoperative pain, non-traumatic subarachnoid hemorrhage, multimodal analgesia

Received: 27.11.2017


References

  1. Rabinstein A.A., Lanzino G., Wijdicks E.F. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2010; 9(5): 504–519. doi: 10.1016/S1474–4422(10)70087–9.
  2. Баялиева А.Ж., Шпанер Р.Я., Ганеева И.Р., Насунов С.Ю. В поисках оптимального лечения головной боли при нетравматическом субарахноидальном кровоизлиянии. Анестезиология иреаниматология. 2017; 2: 149–152. [Bayalieva A.Zh., Shpaner R.Ja., Ganeeva I.R., Nasunov S.Ju. Searching the Optimal Treatment of Headache in Non-traumatic Subarachnoid Hemorrhage. Anaesthesiology and Reanimatology. 2017; 2: 149–152. (In Russ)]
  3. БаялиеваА.Ж., Шпанер Р.Я., Ганеева И.Р. Опыт лечения головной боли при остром нетравматическом субарахноидальном кровоизлиянии и оценка эффективности терапии. Казанский медицинский журнал. 2016; 6: 841–845. [Bayalieva A.Zh., Shpaner R.Ja., Ganeeva I.R. Practice in the treatment of headache in acute Non-traumatic Subarachnoid Hemorrhage and evaluation of the effectiveness of therapy. Kazan medical journal. 2016; 6: 841–845. (In Russ)]
  4. Mahon P., Smith B., Browne J., et al. Effective headache management in the aneurysmal subarachnoid patient: a literature review. British Journal of Neuroscience Nursing. 2012; 8(2): 89–93.
  5. Ганеева И.Р. Лечение головной боли у пациентов с нетравматическим субарахноидальным кровоизлиянием в интенсивной терапии. Регионарная анестезия илечение острой боли. 2017; 3: 164–169. [Ganeeva I.R. Management of headache in patients with non-traumatic subarachnoid hemorrhage. Regional anesthesia and treatment of acute pain. 2017; 3: 164–165. (In Russ)]
  6. Harrison R.A., Field T.S. Post stroke pain: identification, assessment, and therapy. Cerebrovasc. Dis. 2015; 39: 190–201. doi: 10.1159/000375397.
  7. Naess H., Lunde L., Brogger J. The effects of fatigue, pain, and depression on quality of life in ischemic stroke patients: the bergen stroke study. Vasc. Health Risk. Manag. 2012; 8: 407–413. doi: 10.2147/VHRM.S32780.
  8. O’Donnell M.J., Diener H.C., Sacco R.L., et al. Chronic pain syndromes after ischemic stroke: PRoFESS trial. Stroke. 2013; 44: 1238–1243. doi: 10.1161/STROKEAHA.111.671008.
  9. Hoang C.L., Salle J.Y., Mandigout S., et al. Physical factors associated with fatigue after stroke: an exploratory study. Top. Stroke Rehabil. 2012; 19: 369–376. doi: 10.1310/tsr1905–369.
  10. Lundström E., Smits A., Terént A., Borg J. Risk factors for stroke-related pain 1 year after first-ever stroke. Eur. J. Neurol. 2009; 16: 188–193. doi: 10.1111/j.1468-1331.2008.02378.x.
  11. Tang W.K., Liang H., Mok V., et al. Is pain associated with suicidality in stroke? Arch.Phys. Med. Rehabil. 2013; 94: 863–866. doi: 10.1016/j.apmr.2012.11.044.
  12. Овечкин А.М., Политов М.Е. Послеоперационное обезболивание с точки зрения доказательной медицины. Вестн. инт. терапии. 2016; 2: 51–60. [Ovechkin A.M., Politov M.E. Postoperative analgesia from evidence based medicine. Vestnik Intensivnoi Terapii. 2016; 2: 51–60. (In Russ)]
  13. Dorhout Mees S.M. MASH-II study group. Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial. International Journal of Stroke. 2008; 3(1): 63–65. doi: 10.1111/j.1747-4949.2008.00168.x.
  14. Dorhout Mees S.M., Bertens D., van der Worp H.B.et al. Magnesium and headache after aneurysmal subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry. 2010; 81: 490–493. doi:10.1136/jnnp.2009.181404.
  15. Glisic E.K. Inadequacy of headache management after subarachnoid hemorrhage. American Journal of Critical Care. 2016; 25(2): 136–143. doi:10.4037/ajcc2016486.